Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 288
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05267912 | Prospective Multicenter Study Evaluating Feasibility and Efficacy of Tumor Organoid-based Precision Medicine in Patients With Advanced Refractory Cancers | ||
| NCT01834950 | Identification of Early Markers of Response and Resistance to Trastuzumab | ||
| NCT01167530 | Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer | ||
| NCT00412503 | Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents | ||
| NCT01180335 | Standard Neoadjuvant Chemotherapy Versus Genomic Driven Chemotherapy in Patients With Breast Cancer | ||
| NCT02008734 | Randomized Phase II Study to Assess PD 0332991 in Breast Cancer | ||
| NCT05283044 | Implementing Precision Medicine in cOmmunity HospiTALs | ||
| NCT04985266 | A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer | ||
| NCT01268202 | Curative Efficacy of Pravastatine in Patients Presented Delayed Cutaneous and Subcutaneous Radio-induced Fibrosis | ||
| NCT03613194 | Mechanistic and Molecular Study of the Process of Metastatic Dissemination in Colorectal Cancer | ||
| NCT00180830 | Glivec Phase II Pediatric Study | ||
| NCT01884623 | Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer | ||
| NCT00918320 | Studies of Temozolomide in Combination With Topotecan in Refractory and Relapsed Paediatric Solid Tumours | ||
| NCT06642844 | Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line Treatment | ||
| NCT02517281 | Prospective Clinical and Biologic Study of Secondary Cutaneous Effects in Targeted Cancer Therapies | ||
| NCT00006112 | Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer | ||
| NCT04775121 | Classical Monocyte Kinetics in Chronic Myelomonocytic Leukemia | ||
| NCT05071001 | Long Term Brain Toxicity of Chemotherapy in Patients Treated for a Bone TumorDuring Childhood or Adolescence | ||
| NCT01516567 | Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation | ||
| NCT00935675 | Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment | ||
| NCT01211938 | Trial Comparing Two Protocols of re Irradiation in an Irradiated Area for Carcinoma of the Upper Aerodigestive Tract | ||
| NCT05180006 | Impact of Neoadjuvant Immunotherapy in Early Stage Breast Cancer Before Standard Therapy | ||
| NCT02233049 | Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication | ||
| NCT04276376 | Efficacy and Safety of the Combination of Rucaparib (PARP Inhibitor) and Atezolizumab (Anti-PD-L1 Antibody) in Patients With DNA Repair-deficient or Platinum-sensitive Solid Tumors | ||
| NCT06160596 | Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis | ||
| NCT06078384 | Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBC | ||
| NCT03402568 | Alcohol Consumption and Circulating Metabolites | ||
| NCT05889585 | Morbidity, Long-term Side Effects and Quality of Life in Germ-cell Tumor Long Survivors Treated with High-dose Chemotherapy and Autologous Stem Cell Transplant | ||
| NCT04224389 | IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas | ||
| NCT03984318 | Predictive Markers of Immune-related Adverse Events in Patients Treated With Immune Stimulatory Drugs | ||
| NCT02044354 | Patient Preference Between Cabazitaxel and Docetaxel in Metastatic Castrate-resistant Prostate Cancer | ||
| NCT02619565 | Prospective Study of Molecular Predictors of Survival in Myelodysplastic Syndromes | ||
| NCT00180856 | Radiofrequency Ablation of Lung Tumors | ||
| NCT05215106 | Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva) | ||
| NCT06828263 | Prospective Evaluation of Imaging Response Biomarkers During [177Lu]Lu-PSMA in Metastatic Castration-resistant Prostate Cancer | ||
| NCT03570021 | ESTIMation of the ABiLity of Prophylactic Central Compartment Neck Dissection to Modify Outcomes in Low-risk Differentiated Thyroid Cancer | ||
| NCT00162708 | Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC | ||
| NCT05293197 | Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients | ||
| NCT03324958 | VIrtual REality Glasses for the Enhancement of Acute BRACHYtherapy Tolerance for Endometrial Cancer Patients. | ||
| NCT04341207 | Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients | ||
| NCT05481502 | An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors | ||
| NCT00180791 | High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood | ||
| NCT03612791 | Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab | ||
| NCT01516580 | Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients | ||
| NCT00673010 | Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma | ||
| NCT04826198 | Safety and Efficacy of AsiDNATM, a DNA Repair Inhibitor, Administered Intravenously in Addition to PARP Inhibitors in Patients With Relapsed Platinum Sensitive Ovarian Cancer Already Treated With PARP Inhibitors Since at Least 6 Months | ||
| NCT01403324 | Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer | ||
| NCT07431502 | Trial to Evaluate Nonavalent HPV Vaccine as a Secondary Prevention in Patients Treated for Human Papilloma Virus Related High-grade Squamous Intraepithelial Lesions | ||
| NCT00127049 | Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors | ||
| NCT00346645 | A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer |
